Photoisomerization of Isatogens to Benzoxazin-4-ones Authors: Sasirome Racochote, Chokratchanee Nutthawasutha, Usamah Bado, Chatphorn Theppitak, Jumreang Tummatorn, Somsak Ruchirawat, Charnsak Thongsornkleeb Published: 2026 ABSTRACT A mild photoinduced isomerization of isatogens to benzoxazin-4-ones is described. Upon irradiation at 370 nm, a broad range of 2-aryl- and 2-alkyl-substituted isatogens undergo efficient scaffold reorganization under catalyst-free conditions to afford benzoxazin-4-ones in good to excellent yields. The transformation tolerates diverse substitution patterns, including heteroaryl and strained alkyl groups, and is readily scalable. Mechanistic experiments support participation of an excited-state pathway, and inclusion of catalytic 2-picolinic acid provided reproducible outcomes. For a nitro-substituted substrate, a distinct reaction pathway is observed, leading to the formation of a toluene-derived adduct. These results establish isatogens as versatile photochemical precursors to benzoxazinone scaffolds under operationally simple conditions. Introduction Benzoxazin-4-one derivatives represent an important class of compounds in medicinal chemistry with a broad spectrum of biological activities (Scheme A). For instance, cetilistat, a clinically used pancreatic lipase inhibitor for obesity management, as well as reported HSV-1 protease inhibitors and compounds exhibiting cytotoxicity against P388 leukemia cells, contain benzoxazinone motifs. Owing to their importance, several synthetic routes have been developed (Scheme B). Pd-catalyzed carbonylative cyclization of 2-haloanilines or 2-haloanilides represents a particularly powerful class of methods. Moreover, Cu-driven aza-Wittig reactions or tandem C–N coupling/rearrangement processes have provided complementary access to benzoxazin-4-ones. Starting from indole-type substrates, benzoxazin-4-one derivatives can be accessed via transition-metal-free oxidation of 2-arylindoles using PhI­(OAc)2 or OxoneⓇ, as well as through an FeCl2-catalyzed rearrangement of 3-tert-butylperoxyindol-2-ones. Recent photochemical advances, particularly visible-light-induced decarbonylative C–O functionalization of isatoic anhydrides, have provided a sustainable means of accessing 2-substituted benzoxazin-4-ones through photoactivated electrophilic intermediates. Background of Benzoxazin-4-ones and Photochemical Isomerization via Oxaziridine Intermediates Photoinduced transformations have emerged as one of the most powerful tools in modern organic synthesis. Within this broader framework of light-driven reactivity, nitrones (imine N-oxides) stand out as privileged substrates whose photochemical behavior has been extensively documented. Upon irradiation, they undergo rapid intramolecular cyclization to form oxaziridines, highly strained three-membered N–O heterocycles. Although typically short-lived, oxaziridines serve as key intermediates in photochemical rearrangements (Scheme C). For instance, photoisomerization of pyridine N-oxides or quinoline N-oxides proceeds through oxaziridines to provide 3-pyridinols or quinolin-2­(1H)-ones, respectively. Likewise, nitrones undergo photoinduced rearrangement to amides via oxaziridine ring opening, driven by substituent migration in the excited state. , These established transformations highlight the unusual excited-state chemistry of N–O motifs and point to the potential for related heterocyclic N-oxides, including isatogens, to exhibit analogous photoreactivity. Preceded by Noland’s studies on the thermal ring expansion of isatogens, , the corresponding photochemical variant of this transformation was subsequently investigated. Building on the well-established photochemical behavior of nitrones, Eckroth invoked analogous rigid three-membered N–O intermediates to rationalize the photochemical transformation of isatogens, reporting that irradiation of 2-phenylisatogen with a high-pressure 450 W immersion lamp afforded the corresponding 2-phenyl-4H-3,1-benzoxazin-4-one. , The proposed mechanism involves the formation of a 6,5,3-fused heterocyclic intermediate A (iso-isatogen), followed by homolytic cleavage to generate a diradical intermediate B, which further proceeds to form intermediate C before eventually fragmenting to the benzoxazin-4-one product. Although the formal photoisomerization of isatogens to benzoxazin-4-ones has precedent, early studies were largely limited to few substrates and relied on high-intensity mercury lamp irradiation. As a result, key aspects of this transformationincluding substrate generality, substituent effects on reaction efficiency, and the mechanistic features governing the excited-state pathwayremain insufficiently understood. These limitations have constrained the broader synthetic development of this rearrangement and motivated a systematic reinvestigation under controlled photochemical conditions. Herein, we present a systematic study of the photoinduced isomerization of isatogens to benzoxazin-4-ones under mild LED irradiation. The transformation proceeds under operationally simple conditions without external photocatalysts, and a Brønsted acid additive was employed under the optimized conditions to provide reproducible outcomes. Results and Discussion As summarized in Table , the photoreactivity of isatogen 1a was investigated. Under irradiation at 370 nm for 16 h in toluene (0.1 M) with the reaction tube positioned 4 cm from the light source (entry 1), benzoxazinone 2a was formed predominantly and was obtained in 86% yield after chromatographic isolation, displaying spectroscopic data consistent with the literature. Optimization of reaction conditions for the light-driven isomerization began with a solvent screen (entries 1–6), identifying toluene as the most effective medium. However, a lower yield was significantly observed when the reaction concentration was increased (entry 1 vs entry 7). The rearrangement proceeded efficiently even in the absence of additives, affording 2a in 86% yield under otherwise identical conditions. However, the inclusion of catalytic 2-picolinic acid provided a modest but reproducible improvement in yield and reaction consistency, affording 2a in 90% yield, whereas CuTC alone or its combination with 2-picolinic acid provided clearly inferior yields (entries 8–10). Although the precise role of 2-picolinic acid remains unclear, it may facilitate the rearrangement through hydrogen-bonding or proton-transfer interactions with the N-oxide functionality. Consistent with this interpretation, 2-picolinic acid has been reported to promote epoxide ring opening via hydrogen-bond donation. More broadly, acid additives are frequently employed in photochemical reactions, where they can facilitate proton-coupled electron transfer (PCET) processes, , although such a mechanism is not established in the present system. These observations suggested that acid additives may influence reaction efficiency; therefore, various acids were further examined (entries 9, 11–15). Among the additives examined, 2-picolinic acid provided the most consistent reaction outcomes. Aromatic solvent effects were also probed, and other aromatic solvents (benzene, xylene) were less effective (entries 16–17). Notably, decreasing the distance between the light source and the reaction tube to 2 cm markedly accelerated the transformation, affording 2a in 94% yield within 10 h, even with only 5 mol % of 2-picolinic acid. These results indicate a strong dependence of the reaction rate on photon flux. Finally, irradiation at longer wavelengths (440, 467, and 525 nm) led to diminished reactivity, underscoring 370 nm as the optimal excitation source. To rationalize the choice of irradiation wavelength, the ultraviolet–visible (UV–vis) absorption spectra of representative isatogen 1a were recorded. The substrate exhibits long-wavelength absorption bands with λmax at approximately 455 nm in toluene and 447 nm in MeCN, indicating substantial absorption extending into the near-visible region. These spectral features are consistent with efficient excitation under 370-nm irradiation, which lies within the strong absorption envelope of the chromophore. Although the absorption maximum occurs at longer wavelength, irradiation at 370 nm provides higher photon energy and a more efficient population of the reactive excited state, leading to improved photochemical conversion. 1Reaction Optimization Studies entrylight sourceadditive (mol %)solvent (M)time (h) 2a (%) 1370-nm LED-toluene (0.1)16862370-nm LED-cyclohexane (0.1)16603370-nm LED-THF (0.1)16544370-nm LED-MeCN (0.1)16345370-nm LED-DMF (0.1)16366370-nm LED-acetone (0.1)16697370-nm LED-toluene (0.2)16628370-nm LEDCuTC (5)toluene (0.1)16529370-nm LED2-picolinic acid (10)toluene (0.1)169010370-nm LEDCuTC (5) + 2-picolinic acid (10)toluene (0.1)167311370-nm LED p-TsOH·H2O (10)toluene (0.1)165512370-nm LEDMsOH (10)toluene (0.1)167313370-nm LEDbenzoic acid (10)toluene (0.1)167414370-nm LEDTfOH (10)toluene (0.1)163715370-nm LEDTFA (10)toluene (0.1)167716370-nm LED2-picolinic acid (10)benzene (0.1)166817370-nm LED2-picolinic acid (10)xylene (0.1)165918 370-nm LED2-picolinic acid (10)toluene (0.1)1647 19 370-nm LED 2-picolinic acid (5) toluene (0.1) 10 94 20 440-nm LED2-picolinic acid (5)toluene (0.1)107321 467-nm LED2-picolinic acid (5)toluene (0.1)102822 525-nm LED2-picolinic acid (5)toluene (0.1)10NRaThe reaction was carried out using 1a (0.2240 mmol) at room temperature (rt) in a seal tube positioned at a distance of 4 cm from the light source.bIsolated yield.cThe reaction was carried out in a vial positioned at a distance of 6 cm from the light source.dThe seal tube was positioned at a distance of 2 cm from the light source. NR = No reaction. Reaction Optimization Studies The reaction was carried out using 1a (0.2240 mmol) at room temperature (rt) in a seal tube positioned at a distance of 4 cm from the light source. Isolated yield. The reaction was carried out in a vial positioned at a distance of 6 cm from the light source. The seal tube was positioned at a distance of 2 cm from the light source. NR = No reaction. Under the optimal conditions, 2-picolinic acid (5 mol %) was selected as a convenient additive that provided reproducible reaction performance under the standard conditions. Under these conditions, photoisomerization of isatogen 1a under 370-nm irradiation in toluene afforded 2a in 94% yield after 10 h. In addition to toluene, acetonitrile (MeCN) was also found to be a suitable solvent, in some substrates providing improved yields relative to toluene. The scope of the reaction was next examined as illustrated in Scheme . Several isatogen substrates employed in this study were prepared via several established methods. − C5-substituted isatogens (1b–1g) were first examined under the optimized photochemical conditions. For isatogen 1b (5-Me), the reaction furnished 2b in 20% yield after 10 h, which increased modestly to 28% upon prolonged irradiation (24 h). Conducting this reaction in MeCN did not lead to any improvement, affording product 2b in 22% yield. For substrates 1c (5-OMe) and 1d (5-F), the reactions afforded the corresponding products in low yields (2c, 28%; 2d, 31%) after 32 h in toluene. However, conducting these reactions in MeCN instead of toluene led to notably improved outcomes, delivering 2c and 2d in higher yields, 82% and 57%, respectively. Substrate Scope of the Photoinduced Isomerization of Isatogens 1 , ,c cYield of the reaction conducted in MeCN. aThe reaction was carried out using substrates 1 (0.224 mmol), 2-picolinic acid (5 mol %, 0.0112 mmol) in toluene (0.1 M) at rt in a sealed tube positioned at 2 cm from the light source. bIsolated yield of the analytically pure product after purification by SiO2 column chromatography. Yield of the reaction conducted in MeCN. The reaction was carried out using substrates 1 (0.224 mmol), 2-picolinic acid (5 mol %, 0.0112 mmol) in toluene (0.1 M) at rt in a sealed tube positioned at 2 cm from the light source. Isolated yield of the analytically pure product after purification by SiO2 column chromatography. These observations indicate that the efficiency of the transformation is sensitive to both substituent effects and reaction medium. In contrast to 1b–1d, C5-substituted derivatives bearing 5-Cl (1e) and 5-CF3 (1f) underwent smooth photoisomerization under the standard conditions, affording 2e (82%) and 2f (92%) in high yields. However, incorporation of a strongly electron-withdrawing 5-NO2 substituent (1g) markedly diminished reactivity, providing 2g in only 17% yield. For this low-yielding case, conducting the reactions in MeCN did not lead to improved outcomes. In contrast to the C5-substituted series, C6-substituted isatogens 1h–1l (6-Me, 6-OMe, 6-F, 6-Cl, and 6-CF3) generally underwent more efficient photoisomerization, affording benzoxazin-4-ones 2h–2l in 60–94% yields within 6–24 h. A consistent trend was observed in which 6-substituted substrates outperformed their 5-substituted counterparts (1h vs 1b, 1i vs 1c, and 1j vs 1d), whereas the differences were less pronounced for the chloro- and trifluoromethyl-substituted derivatives (1k vs 1e and 1l vs 1f). These results suggest that the efficiency of the rearrangement is sensitive to both the electronic nature and positional effects of the substituents. The behavior of the nitro-substituted derivatives further highlights this positional dependence. Substrate 1m (6-NO2) mirrored the reactivity of 1g (5-NO2), with both affording the desired benzoxazin-4-ones in low yields (2g, 17%; 2m, 9%). Notably, irradiation of 1m also led to the formation of an unanticipated bis-benzylated adduct 3m (16%), the structure of which was confirmed by single-crystal X-ray diffraction (CCDC 2528871). The consistently diminished reactivity of the nitro- substituted substrates suggests that the strongly electron-withdrawing substituent perturbs the productive photochemical pathway under the standard conditions. Finally, isatogens bearing 5,7-disubstitution patterns (1n, 5,7-diMe; 1o, 5,7-diCl) underwent smooth photoisomerization to furnish the corresponding benzoxazin-4-ones 2n and 2o in high yields (72% and 87%, respectively), further illustrating the positional sensitivity of the transformation. Substrates bearing variation at the C2 position were next examined. Isatogens 1p–1r featuring isomeric tolyl substituents revealed pronounced positional effects: the 3-tolyl and 4-tolyl derivatives (1q and 1r) afforded 2q and 2r in high yields (91% and 88%, respectively), whereas the sterically encumbered 2-tolyl analog (1p) delivered 2p in a more modest 48% yield. A range of electronically diverse aryl substituents at C2 was then evaluated. Isatogens bearing para-substituted phenyl groups1s (4-OMe-Ph), 1t (4-F-Ph), and 1u (4-CF3–Ph)were well tolerated, furnishing the corresponding products 2s–2u in high yields (85%, 87%, and 72%, respectively). In contrast, incorporation of a strongly electron-withdrawing 4-NO2-phenyl substituent (1v) resulted in diminished reactivity, affording 2v in only 13% yield. An extended aromatic substituent, 2-naphthyl (1w), was also compatible, delivering 2w in 36% yield under the optimized conditions. Heteroaryl-substituted substrates further delineated the scope: 1x and 1y afforded 2x and 2y in 15% and 74% yields, respectively. Finally, replacement of the aryl unit at C2 with simple alkyl groups such as methyl (1z) and ethyl (1aa) remained feasible, although the corresponding products 2z and 2aa were obtained in lower yields (15% and 14%, respectively). Notably, a cyclopropyl-substituted isatogen (1bb) underwent smooth irradiation-induced rearrangement to furnish the cyclopropane-containing product 2bb in 56% yield. The practicality of the method was demonstrated on a preparative scale, as irradiation of 2.24 mmol of isatogen 1a under the optimized conditions furnished benzoxazinone 2a in 90% yield after 24 h (Scheme A). The synthetic utility of this scaffold was further illustrated by conversion of 2a to 2-aminophenone 4, a key synthon in the total synthesis of (±)-yaequinolone A2, via nucleophilic addition of p-anisylmagnesium bromide followed by basic hydrolysis (Scheme B). Finally, isatogen 1cc provided benzoxazinone 2cc in 8% yield under the standard conditions, demonstrating that structurally and biologically relevant benzoxazinone frameworks remain accessible. Demonstration of Synthetic Utilities As shown in Scheme D, the photoisomerization of isatogens was previously investigated under high-intensity irradiation by Eckroth, who employed a 450 W immersion lamp in the absence of additives and observed wavelength-dependent behavior, including the appearance of isosbestic points at selected excitation wavelengths. , In contrast, the present transformation proceeds under substantially milder and operationally simple conditions, using a low-power 370-nm LED without the need for external photocatalysts. Under the optimized conditions, a Brønsted acid additive was employed to ensure consistent performance, and the reaction was found to proceed smoothly in both toluene and MeCN. These features collectively distinguish the current protocol from earlier studies and underscore its practical utility. A series of control experiments was conducted to probe the nature of the reactive intermediates (Scheme ). The addition of radical scavengers such as TEMPO or butylated hydroxytoluene (BHT) had little effect on the formation of 2a, and no radical-trapping adducts were detected. Similarly, reactions performed under argon- or oxygen-rich atmospheres proceeded with comparable efficiency (Scheme A). These observations suggest that long-lived radical chains are unlikely to be central to the productive pathway and that the transformation does not exhibit pronounced oxygen sensitivity. Mechanistic Studies More insight was obtained upon inclusion of 2,5-dimethylhexa-2,4-diene, a known physical triplet quencher, which resulted in a marked decrease in product yield (Scheme B). This suppression is consistent with involvement of an excited state susceptible to energy quenching, while remaining largely insensitive to conventional radical interception. Additional solvent studies provided further insight into the nature of the reactive intermediates (Scheme C). When isatogen 1a was irradiated in EtOH instead of toluene under otherwise identical conditions, the desired isomerization product was obtained together with a trace amount of ester side-product (5). Compound 5 was detected by crude NMR and HRMS; however, attempts to isolate, purify, and fully characterize it were unsuccessful, likely due to its low abundance arising from rapid intramolecular cyclization to the benzoxazin-4-one, which outcompetes solvent trapping. Given that alcoholysis of benzoxazin-4-ones is well precedented under thermal conditions, we considered whether 5 might arise from postrearrangement ring-opening of benzoxazinone 2a. However, subjecting 2a to the same irradiation conditions in EtOH did not produce 5, effectively ruling out a ground-state alcoholysis pathway. The formation of 5 is therefore more consistent with trapping of a ketene–imine-type intermediate (D, Scheme D) by ethanol prior to cyclization. Notably, earlier photochemical studies of isatogens did not report such nucleophilic trapping, even in alcoholic solvents, suggesting that this intermediate was either not formed or not accessible under those conditions. Even in trace amounts, the observation of 5 supports the presence of the ketene–imine-type intermediate (D) in the reaction mixture and underscores a mechanistic distinction from the previously reported photochemical rearrangement by Eckroth. A distinct reactivity profile was observed for the nitro-substituted substrate 1m (Scheme D). In this case, formation of the canonical isomerization product was strongly suppressed, and a benzylated product derived from the toluene solvent became prominent. The nitro group is known to influence excited-state behavior, and its presence may perturb the productive intramolecular pathway, thereby allowing alternative processes involving solvent participation to emerge. The incorporation of two benzyl units in the resulting product underscores the sensitivity of the reaction to subtle electronic modification of the substrate. Taken together, these results support a mechanism involving a short-lived, intramolecular excited-state process that is distinct from stepwise radical pathways. The observed sensitivity to triplet quenching, combined with the resistance to radical traps and the pronounced electronic effects, suggests that excited-state deactivation and energy-transfer processes play an important role in governing product formation under the mild irradiation conditions employed. On the basis of the experimental observations, a plausible mechanistic pathway is depicted in Scheme . The suppression of product formation by a physical triplet quencher, together with the lack of inhibition by conventional radical traps and the observation of solvent interception in ethanol, collectively supports the involvement of a short-lived excited-state intermediate rather than a stepwise radical chain process. Upon irradiation at 370 nm, isatogen 1 (R) is promoted to its singlet excited state (1 R* ), which may undergo excited-state reorganization, potentially assisted by hydrogen-bonding interactions with the additive to give an iso-isatogen species. Intersystem crossing (ISC) to the triplet state (3 R* ) is proposed to precede rearrangement to a highly reactive ketene–imine–like intermediate. In the absence of external traps, the transient ketene–imine–like intermediate is proposed to undergo rapid intramolecular cyclization and relaxation to furnish benzoxazin-4-one 2. Solvent-trapping experiments in ethanol led to the formation of ester 5, whereas isolated 2a did not undergo alcoholysis under identical conditions, consistent with interception of the intermediate prior to cyclization. The altered reactivity observed for nitro-substituted substrates further suggests that subtle electronic perturbations can redirect the excited-state mechanism, enabling competing solvent-participating pathways. Collectively, these findings support a short-lived, intramolecular excited-state rearrangement as the dominant productive process under the mild photochemical conditions employed. Proposed Reaction Mechanisms Conclusions In conclusion, we have developed a mild photoinduced isomerization of isatogens to benzoxazin-4-ones under operationally simple conditions. The transformation exhibits broad substrate scope (29 examples) and is amenable to preparative-scale synthesis. Mechanistic studies support an excited-state pathway that is susceptible to triplet quenching, largely insensitive to radical traps, and capable of generating transient intermediates that can be intercepted by nucleophilic solvents. The synthetic utility of the benzoxazinone framework was demonstrated through its conversion to 2-aminophenone 4, a key synthon in the total synthesis of (±)-yaequinolone A2. These findings provide new insight into the photochemical behavior of isatogens and highlight their potential as versatile precursors to benzoxazinone scaffolds. Experimental Section General Information Commercial-grade chemicals were used without additional purification unless otherwise noted. All solvents were used as received. Reactions were conducted in glassware that was either flame-dried or oven-dried at 110 °C for 2 h. Crude reaction mixtures were concentrated under reduced pressure using a rotary evaporator. Column chromatography was performed on silica gel 60 (particle size 0.06–0.2 mm; 70–230 mesh ASTM). Developed thin-layer chromatography (TLC) plates, made of silica gel 60 F254 aluminum sheets, were visualized under UV light (254 and 366 nm) and subsequently heated with p-anisaldehyde or KMnO4. Nuclear magnetic resonance (NMR) spectra were recorded in deuterochloroform (CDCl3) using 300, 400, and 600 MHz spectrometers. Chemical shifts for 1H NMR and 13C­{1H} NMR are reported in parts per million (ppm, δ), relative to tetramethylsilane (TMS) as the internal reference. 19F NMR spectra are reported in parts per million (ppm, δ), relative to hexafluorobenzene as the internal reference. Coupling constants (J) are reported in Hertz (Hz). Infrared spectra were measured using an FT-IR spectrophotometer and are reported in cm–1. High-resolution mass spectra (HRMS) were obtained using a mass spectrometer equipped with an electrospray ionization (ESI) and an Orbitrap system. Preparation of Compounds 1a–w 1cc (Representative Procedure: Preparation of Compound 1a) A 25-mL sealed tube was charged with 2-bromoaniline (869.2 mg, 5.0 mmol, 1.0 equiv), Pd­(OAc)2 (11.3 mg, 0.05 mmol, 1 mol %), tri­(o-tolyl)­phosphine (121.7 mg, 0.40 mmol, 8 mol %), and styrene (0.69 mL, 625.1 mg, 6.0 mmol, 1.2 equiv). Triethylamine (2 mL) was then added, and the tube was tightly sealed. The reaction was heated in an oil bath at 125 °C for 24 h after which it was quenched with H2O (10 mL). The resulting mixture was extracted with CH2Cl2 (3 × 10 mL), and the combined organic phases were washed with saturated aqueous NaCl and dried over anhydrous Na2SO4. After concentration under reduced pressure, the crude product was purified by column chromatography on silica gel (10% EtOAc-hexanes) to afford (E)-2-styrylaniline (737.7 mg, 76% yield) as a yellow solid. In a 50-mL round-bottomed flask, (E)-2-styrylaniline (737.7 mg, 3.78 mmol, 1.0 equiv) was dissolved in CH2Cl2 (38 mL, 0.1 M) and the resulting solution was added with m-CPBA (3.92 g, 22.7 mmol, 6.0 equiv) in portions over 15 min at room temperature. After stirring for 5 min, the reaction was quenched with saturated aqueous NaHCO3 and stirred for an additional 5 min. The resulting mixture was extracted with CH2Cl2 (3 × 10 mL), washed with saturated aqueous NaCl and dried over anhydrous Na2SO4. Upon filtration and concentration under reduced pressure, crude solid was obtained. The crude solid was taken up in MeOH and the mixture was filtered through a Buchner funnel. The remaining solid on the funnel was washed with an ample amount of MeOH and dried to give isatogen 1a (586.0 mg, 70% yield) as a red solid. Preparation of Compounds 1x–y and 1bb (Representative Procedure: Preparation of Compound 1x) A 50-mL sealed tube was charged with 2-iodonitrobenzene (597.9 mg, 2.4 mmol, 1.2 equiv) and 2-ethynylpyridine (0.21 mL, 214.4 mg, 2.0 mmol, 1.0 equiv) in Et3N (32 mL) and DMF (16 mL). The mixture was then sequentially added with Pd­(PPh3)2Cl2 (140.4 mg, 0.2 mmol, 10 mol %) and PPh3 (52.5 mg, 0.2 mmol, 10 mol %), and the resulting mixture was degassed with a steady stream of argon for 30 min. CuI (38.1 mg, 0.2 mmol, 10 mol %) was then added, and the mixture was further degassed with argon for 10 min and allowed to stir at room temperature. After 14 h, the reaction was quenched with H2O (100 mL), and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic phases were washed with H2O (3 × 100 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (2% EtOAc-hexanes) to afford 2-((2-nitrophenyl)­ethynyl)­pyridine (355.4 mg, 79% yield) as a brown solid. The purified 2-alkynylnitrobenzene (354.8 mg, 1.59 mmol) was dissolved in CH3CN (48 mL). The resulting solution was added with Pd­(CH3CN)2Cl2 (20.5 mg, 0.08 mmol, 5 mol %) and allowed to stir under argon at 100 °C until complete (72 h) as monitored by TLC. Upon completion, the reaction mixture was concentrated under reduced pressure to afford the crude product, which was directly purified by column chromatography on silica gel (20% EtOAc-hexanes) to afford compound 1x (274.0 mg, 77% yield) as a yellow solid. Preparation of Compounds 1z and 1aa (Representative Procedure: Preparation of Compound 1z) To a solution of ethyltriphenylphosphonium iodide (2.09 g, 5.17 mmol, 1.0 equiv) in dry THF (10 mL) was added NaH (60% w/w, 240.0 mg, 6.0 mmol, 1.2 equiv) at 0 °C. The resulting suspension was allowed to stir while warming to room temperature over 1 h before a solution of 2-nitrobenzaldehyde (906.1 mg, 6.0 mmol, 1.2 equiv) in dry THF (20 mL) was added to the suspension dropwise. The mixture was then stirred at room temperature for 24 h and quenched with saturated aqueous NH4Cl. The mixture was extracted with EtOAc (3 × 20 mL), washed with saturated aqueous NaCl, dried over anhydrous Na2SO4 and concentrated to crude material. The crude product was purified by column chromatography on silica gel (1% EtOAc-hexanes) to afford 1-nitro-2-(prop-1-en-1-yl)­benzene (657.9 mg, 81% yield) as a yellow oil. This material (355.0 mg, 2.2 mmol, 1.0 equiv) was dissolved in acetic anhydride (8 mL) at 0 °C and was added with KMnO4 (1.38 g, 8.7 mmol, 4.0 equiv) in five portions over 20 min. The resulting mixture was allowed to stir at 0 °C for an additional 2 h and then added with 10% aqueous sodium dithionite (10 mL) and diluted with EtOAc-cyclohexane (1:1, 10 mL). The mixture continued to stir in the cooling bath for 10 min, and the organic phase was separated, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to give a yellow residue. The residue was taken up in CH2Cl2 (10 mL) and subsequently neutralized with saturated aqueous NaHCO3. The mixture was extracted with CH2Cl2 (3 × 10 mL), and the combined organic phases were washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The resulting crude material was purified by column chromatography on silica gel (40% CH2Cl2-hexanes) to afford 1-(2-nitrophenyl)­propane-1,2-dione (151.8 mg, 36% yield) as a yellow solid. The diketone (273.7 mg, 1.42 mmol) was dissolved in THF (24 mL), and the solution was added with an in THF (24 mL) and the aqueous solution of NH4Cl (2.43 g, 45.3 mmol in H2O 25 mL, 31.9 equiv) and Zn (416.1 mg, 6.37 mmol, 4.5 equiv). The mixture was vigorously stirred at room temperature for 1 h and the organic phase was separated, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to give a bright yellow residue. The residue was subsequently dissolved in THF (25 mL) and then heated in an oil bath at 80 °C for 16 h. Upon complete disappearance of the hydroxylamine intermediate, the reaction mixture was concentrated under reduced pressure to give the crude product which was purified by column chromatography on silica gel (5% EtOAc-hexanes) to afford 2-methylisatogen (1z) (130.7 mg, 57% yield) as a yellow solid. (E)-2-(3-Methylstyryl)-4-nitroaniline 20% EtOAc-hexanes, yield 256.1 mg (50%, orange solid); mp 111–113 °C; IR (neat); νmax 3375, 1637, 1575, 1484, 1290, 1188, 1094 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 2.6 Hz, 1H), 7.92 (dd, J = 2.6, 8.9 Hz, 1H), 7.26–7.18 (m, 3H), 7.06 (d, J = 7.2 Hz, 1H), 6.95 (ABq, J = 16.0 Hz, 2H), 6.60 (d, J = 8.9 Hz, 1H), 4.47 (brs, 2H), 2.32 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 149.9, 139.5, 138.4, 136.5, 133.4, 129.2, 128.7, 127.3, 124.7, 123.9, 123.6, 122.8, 121.3, 114.5, 21.4; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H15N2O2 255.1128; found 255.1124. 2-[(2-Nitrophenyl)­ethynyl]­pyridine 20% EtOAc-hexanes, yield 355.4 mg (79%, brown solid); 1H NMR (300 MHz, CDCl3) δ 8.66 (d, J = 4.5 Hz, 1H), 8.12 (dd, J = 1.1, 8.2 Hz, 1H), 7.82 (dd, J = 1.4, 7.7 Hz, 1H), 7.73 (ddd, J = 1.7, 7.7, 7.7 Hz, 1H), 7.67–7.60 (m, 2H), 7.72 (ddd, J = 1.4, 8.2, 8.2 Hz, 1H), 7.30 (ddd, J = 1.4, 4.5, 7.7 Hz, 1H). Characterization data are in agreement with the literature. 2-[(2-Nitrophenyl)­ethynyl]­thiophene 2% EtOAc-hexanes, yield 435.3 mg (95%, red oil); 1H NMR (300 MHz, CDCl3) δ 8.11 (dd, J = 1.0, 8.3 Hz, 1H), 7.70 (dd, J = 1.5, 7.7 Hz, 1H), 7.60 (ddd, J = 1.5, 7.7, 7.7 Hz, 1H), 7.46 (ddd, J = 1.5, 7.7, 8.3 Hz, 1H), 7.42–7.36 (m, 2H), 7.05 (dd, J = 3.7, 5.1 Hz, 1H). Characterization data are in agreement with the literature. 1-(Cyclopropylethynyl)-2-nitrobenzene 2% EtOAc-hexanes, yield 316.6 mg (85%, yellow oil); 1H NMR (300 MHz, CDCl3) δ 7.97 (dd, J = 0.7, 8.3 Hz, 1H), 7.57–7.47 (m, 2H), 7.37 (ddd, J = 1.9, 7.1, 8.3 Hz, 1H), 1.56–1.47 (m, 1H), 0.98–0.87 (m, 4H). Characterization data are in agreement with the literature. 1-(2-Nitrophenyl)­propane-1,2-dione 40% CH2Cl2-hexanes, yield 151.8 mg (36%, yellow solid); mp 68–69 °C; IR (neat); νmax 1702, 1523, 1443, 1341, 1172 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.18 (dd, J = 1.0, 8.0 Hz, 1H), 7.81 (ddd, J = 1.0, 7.5, 7.5 Hz, 1H), 7.72 (ddd, J = 1.5, 8.0, 8.0 Hz, 1H), 7.58 (dd, J = 1.5, 7.5 Hz, 1H), 2.56 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 196.0, 189.6, 147.3, 134.9, 132.4, 132.2, 130.1, 123.9, 24.2; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C9H8NO4 194.0448; found 194.0449. 1-(2-Nitrophenyl)­butane-1,2-dione 40% CH2Cl2-hexanes, yield 172.0 mg (39%, yellow oil); IR (neat); νmax 1703, 1524, 1343, 1282, 1131 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.18 (dd, J = 1.0, 8.0 Hz, 1H), 7.81 (ddd, J = 1.0, 7.5, 7.5 Hz, 1H), 7.71 (ddd, J = 1.5, 8.0, 8.0 Hz, 1H), 7.58 (dd, J = 1.5, 7.5 Hz, 1H), 3.03 (q, J = 7.3 Hz, 2H), 1.16 (t, J = 7.3 Hz, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 198.7, 189.8, 147.3, 134.8, 132.6, 132.1, 130.1, 123.9, 30.0, 6.7; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C10H10NO4 208.0604; found 208.0605. 3-Oxo-2-(pyridin-2-yl)-3H-indole 1-Oxide (1x) 20% EtOAc-hexanes, 100 °C, 72 h, yield 274.0 mg (77%, yellow solid); 1H NMR (400 MHz, CDCl3) δ 8.89 (d, J = 4.8 Hz, 1H), 8.48 (d, J = 8.0 Hz, 1H), 7.85 (ddd, J = 1.8, 7.8, 7.8 Hz, 1H), 7.78–7.69 (m, 3H), 7.65–7.58 (m, 1H), 7.35 (ddd, J = 1.0, 4.8, 7.8 Hz, 1H). Characterization data are in agreement with the literature. 3-Oxo-2-(thiophen-2-yl)-3H-indole 1-Oxide (1y) 30% CH2Cl2-hexanes, rt, 24 h, yield 341.0 mg (79%, fine red solid); 1H NMR (400 MHz, CDCl3) δ 8.44 (dd, J = 0.9, 3.9 Hz, 1H), 7.72–7.59 (m, 4H), 7.50 (ddd, J = 1.9, 7.0, 7.0 Hz, 1H), 7.28–7.25 (m, 1H). Characterization data are in agreement with the literature. 2-Methyl-3-oxo-3H-indole 1-Oxide (1z) 5% EtOAc-hexanes, yield 130.7 mg (57%, yellow solid); mp 119–121 °C; IR (neat); νmax 1702, 1600, 1546, 1396, 1348, 1288, 1148 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.68–7.60 (m, 2H), 7.59–7.55 (m, 1H), 7.52 (ddd, J = 1.5, 7.1, 7.1 Hz, 1H), 2.21 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 186.7, 147.4, 136.1, 134.4, 130.9, 123.2, 121.4, 113.7, 6.7; HRMS (ESI-Orbitrap) m/z (M+H)+ calcd for C9H8NO2 162.0550; found 162.0547. 2-Ethyl-3-oxo-3H-indole 1-Oxide (1aa) 5% EtOAc-hexanes, yield 97.5 mg (38%, yellow solid); mp 69–71 °C; IR (neat); νmax 1702, 1604, 1534, 1390, 1308, 1078 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.65–7.58 (m, 2H), 7.58–7.53 (m, 1H), 7.50 (ddd, J = 1.4, 7.0, 7.0 Hz, 1H), 2.69 (q, J = 7.6 Hz, 2H), 1.23 (t, J = 7.6 Hz, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 186.7, 147.4, 140.0, 134.3, 130.9, 123.2, 121.3, 113.7, 14.9, 9.7; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C10H10NO2 176.0706; found 176.0703. 2-Cyclopropyl-3-oxo-3H-indole 1-Oxide (1bb) 5% EtOAc-hexanes, 100 °C, 72 h, yield 50.3 mg (14%, red solid); 1H NMR (600 MHz, CDCl3) δ 7.61 (dd, J = 7.5, 7.5 Hz, 1H), 7.55 (d, J = 7.5 Hz, 1H), 7.51–7.40 (m, 2H), 2.25–2.17 (m, 1H), 1.59–1.54 (m, 2H), 1.15–1.10 (m, 2H). Characterization data are in agreement with the literature. 5-Nitro-3-oxo-2-(m-tolyl)-3H-indole 1-Oxide (1cc) Yield 79.1 mg (29%, orange solid); mp 202–204 °C; IR (neat); νmax 1712, 1607, 1537, 1343, 1251, 1085 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.63 (dd, J = 2.1, 8.4 Hz, 1H), 8.55–8.40 (m, 3H), 7.89 (d, J = 8.4 Hz, 1H), 7.44 (dd, J = 7.5, 7.5 Hz, 1H), 7.36 (d, J = 7.5 Hz, 1H), 2.46 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 184.2, 150.9, 150.0, 138.6, 135.0, 132.8, 130.6, 128.7, 128.4, 125.3, 125.1, 124.0, 117.1, 115.1, 21.6; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H11N2O4 283.0713; found 283.0711. Preparation of 2-Substituted 4H-3,1-Benzoxazin-4-one Derivatives 2 (Representative Procedure: Preparation of Compound 2a) A sealed tube equipped with a magnetic bar was charged with 1a (50.2 mg, 0.2240 mmol), 2-picolinic acid (1.4 mg, 0.0112 mmol, 5 mol %), and toluene (2.2 mL, 0.1 M). The reaction tube was sealed tightly, and the mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) with the LED positioned 2 cm from the reaction tube for 10 h at rt. After completion of the reaction, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with saturated aqueous NaCl (20 mL) and dried over anhydrous Na2SO4. After removal of the solvent under reduced pressure, the residue was purified by column chromatography, eluting with 5% EtOAc-hexanes, to afford 2a (47.4 mg, 94% yield) as a white solid. A scale-up protocol was conducted in a 100 mL round-bottomed flask using 1a (500.0 mg, 2.24 mmol, 1.0 equiv), 2-picolinic acid (14.0 mg, 0.112 mmol, 5 mol %), and toluene (22 mL, 0.1 M). The reaction flask was placed between two LED lamps (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) with each LED positioned 2 cm from the reaction flask for 24 h at rt. After completion of the reaction, the mixture was quenched with a saturated aqueous NaHCO3 (50 mL) and extracted with EtOAc (3 × 20 mL). The combined organic phases were washed with saturated aqueous NaCl (30 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The remaining crude residue was purified by column chromatography, eluting with 5% EtOAc-hexanes, to afford compound 2a (451.5 mg, 90% yield) as a white solid. 2-Phenyl-4H-3,1-benzoxazin-4-one (2a) 10 h, 5% EtOAc-hexanes, yield 47.4 mg (94%, white solid); mp 121–122 °C; IR (neat); νmax 1759, 1598, 1493, 1314, 1248, 1060, 1010, 792, 684 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.36–8.28 (m, 2H), 8.25 (dd, J = 1.5, 8.0 Hz, 1H), 7.83 (ddd, J = 1.5, 7.3, 8.0 Hz, 1H), 7.70 (d, J = 8.0 Hz, 1H), 7.61–7.55 (m, 1H), 7.55–7.48 (m, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.6, 157.1, 147.0, 136.6, 132.6, 130.3, 128.7, 128.6, 128.3, 128.2, 127.2, 117.0; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H10NO2 224.0706; found 224.0702. 6-Methyl-2-phenyl-4H-3,1-benzoxazin-4-one (2b) 24 h, 5% EtOAc-hexanes, yield 14.7 mg (28%, orange solid); mp 139–140 °C; IR (neat); νmax 1751, 1611, 1496, 1262, 1045, 837 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.35–8.22 (m, 2H), 8.03 (s, 1H), 7.66–7.53 (m, 3H), 7.53–7.46 (m, 2H), 2.49 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.7, 156.4, 144.8, 138.7, 137.8, 132.4, 130.4, 128.7, 128.1, 127.0, 116.7, 21.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO2 238.0863; found 238.0860. 6-Methoxy-2-phenyl-4H-3,1-benzoxazin-4-one (2c) 32 h, 5% EtOAc-hexanes, in toluene; yield 16.1 mg (28%, pale purple solid), in MeCN; yield 46.5 mg (82%, pale purple solid); mp 144–145 °C; IR (neat); νmax 1752, 1625, 1496, 1353, 1253, 1025 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.34–8.23 (m, 2H), 7.66–7.59 (m, 2H), 7.58–7.53 (m, 1H), 7.53–7.46 (m, 2H), 7.39 (dd, J = 2.9, 8.9 Hz, 1H), 3.92 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.8, 159.3, 155.3, 141.2, 132.2, 130.4, 128.7, 128.6, 128.0, 125.9, 117.8, 108.7, 55.9; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO3 254.0812; found 254.0806. 6-Fluoro-2-phenyl-4H-3,1-benzoxazin-4-one (2d) 32 h, 5% EtOAc-hexanes, in toluene; yield 17.0 mg (31%, pale red solid), in MeCN; yield 30.9 mg (57%, pale red solid); mp 135–136 °C; IR (neat); νmax 1752, 1626, 1482, 1270, 1056, 811 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.35–8.24 (m, 2H), 7.89 (dd, J = 2.9, 7.8 Hz, 1H), 7.71 (dd, J = 4.8, 8.9 Hz, 1H), 7.62–7.48 (m, 4H); 13C­{1H} NMR (101 MHz, CDCl3) δ 161.4 (d, C–F, 1 J C–F = 252 Hz), 158.8 (d, C–F, 4 J C–F = 3 Hz), 156.5 (d, C–F, 4 J C–F = 2 Hz), 143.6 (d, C–F, 4 J C–F = 2 Hz), 132.7, 130.0, 129.6 (d, C–F, 3 J C–F = 8 Hz), 128.8, 128.2, 124.7 (d, C–F, 2 J C–F = 24 Hz), 118.3 (d, C–F, 3 J C–F = 9 Hz), 113.9 (d, C–F, 2 J C–F = 24 Hz); 19F NMR (376 MHz, CDCl3) δ – 113.16 – – 113.21 (m); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9FNO2 242.0612; found 242.0608. 6-Chloro-2-phenyl-4H-3,1-benzoxazin-4-one (2e) 24 h, 5% EtOAc-hexanes, yield 47.2 mg (82%, white solid); mp 192–193 °C; IR (neat); νmax 1754, 1674, 1578, 1469, 1255, 1201,1058, 857, 775 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.34–8.25 (m, 2H), 8.19 (d, J = 2.3 Hz, 1H), 7.75 (dd, J = 2.3, 8.6 Hz, 1H), 7.63 (d, J = 8.6 Hz, 1H), 7.61–7.55 (m, 1H), 7.54–7.47 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 158.4, 157.3, 145.5, 136.8, 133.8, 132.9, 129.8, 128.8, 128.7, 128.3, 127.9, 118.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9ClNO2 258.0316; found 258.0316. 6-Trifluoromethyl-2-phenyl-4H-3,1-benzoxazin-4-one (2f) 24 h, 5% EtOAc-hexanes, yield 60.2 mg (92%, white solid); mp 110–111 °C; IR (neat); νmax 1760, 1609, 1573, 1498, 1305, 1263, 1197, 1125, 1034, 848, 780 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 8.39–8.25 (m, 2H), 8.03 (dd, J = 2.0, 8.5 Hz, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.65–7.58 (m, 1H), 7.57–7.49 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 158.9, 158.4, 149.4, 133.3, 132.8 (q, C–F, 3 J C–F = 3 Hz), 130.2 (q, C–F, 2 J C–F = 34 Hz), 129.6, 128.9, 128.6, 128.1, 126.3 (q, C–F, 3 J C–F = 4 Hz), 123.2 (q, C–F, 1 J C–F = 274 Hz), 117.1; 19F NMR (376 MHz, CDCl3) δ – 65.8 (s); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H9F3NO2 292.0580; found 292.0574. 6-Nitro-2-phenyl-4H-3,1-benzoxazin-4-one (2g) 24 h, 50% CH2Cl2-hexanes, yield 10.5 mg (17%, orange solid); mp 160–162 °C; IR (neat); νmax 1770, 1609, 1572, 1472, 1340, 1261, 1085 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.08 (d, J = 2.6 Hz, 1H), 8.65 (dd, J = 2.6, 8.9 Hz, 1H), 8.41–8.28 (m, 2H), 7.84 (d, J = 8.9 Hz, 1H), 7.69–7.62 (m, 1H), 7.60–7.52 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 160.0, 157.7, 151.4, 146.4, 133.9, 130.7, 129.2, 129.0, 128.9, 128.7, 124.8, 117.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9N2O4 269.0557; found 269.0554. 7-Methyl-2-phenyl-4H-3,1-benzoxazin-4-one (2h) 24 h, 5% EtOAc-hexanes, yield 32.1 mg (60%, white solid); mp 188–190 °C; IR (neat); νmax 1744, 1612, 1452, 1317, 1267, 1061, 1019 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.34–8.27 (m, 2H), 8.12 (d, J = 8.0 Hz, 1H), 7.61–7.54 (m, 1H), 7.54–7.47 (m, 3H), 7.33 (dd, J = 0.7, 8.0 Hz, 1H), 2.52 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.6, 157.2, 148.1, 147.0, 132.5, 130.4, 129.6, 128.7, 128.4, 128.3, 127.2, 114.4, 22.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO2 238.0863; found 238.0860. 7-Methoxy-2-phenyl-4H-3,1-benzoxazin-4-one (2i) 6 h, 5% EtOAc-hexanes, yield: 52.6 mg (92%, white solid); mp 149–150 °C; IR (neat): νmax 1746, 1604, 1568, 1487, 1444, 1355, 1280, 1202, 1032 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.33–8.26 (m, 2H), 8.75 (d, J = 8.7 Hz, 1H), 7.60–7.55 (m, 1H), 7.54–7.47 (m, 2H), 7.09 (d, J = 2.5 Hz, 1H), 7.04 (dd, J = 2.5, 8.7 Hz, 1H), 3.95 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 166.3, 159.2, 157.9, 149.2, 132.6, 130.3, 130.2, 128.7, 128.3, 117.3, 109.8, 108.9, 55.9; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO3 254.0812; found 254.0806. 7-Fluoro-2-phenyl-4H-3,1-benzoxazin-4-one (2j) 10 h, 5% EtOAc-hexanes, yield: 50.9 mg (94%, white solid); mp 152–153 °C; IR (neat): νmax 1755, 1607, 1581, 1479, 1320, 1297, 1023 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.52–8.17 (m, 3H), 7.64–7.56 (m, 1H), 7.56–7.46 (m, 2H), 7.39–7.30 (m, 1H), 7.25–7.17 (m, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 167.8 (d, C–F, 1 J C–F = 259 Hz), 158.6, 158.4, 149.5 (d, C–F, 3 J C–F = 14 Hz), 133.0, 131.4 (d, C–F, 3 J C–F = 11 Hz), 129.8, 128.8, 128.5, 116.6 (d, C–F, 2 J C–F = 23 Hz), 113.5 (d, C–F, 4 J C–F = 2 Hz), 113.2 (d, C–F, 2 J C–F = 23 Hz); 19F NMR (376 MHz, CDCl3) δ –102.10 –102.16 (m); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9FNO2 242.0612; found 242.0611. 7-Chloro-2-phenyl-4H-3,1-benzoxazin-4-one (2k) 24 h, 5% EtOAc-hexanes, yield: 54.2 mg (94%, white solid); mp 180–182 °C; IR (neat): νmax 1762, 1621, 1597, 1462, 1315, 1237, 1020, 925, 771 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.34–8.26 (m, 2H), 8.16 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 2.0 Hz, 1H), 7.64–7.56 (m, 1H), 7.55–7.49 (m, 2H), 7.47 (dd, J = 2.0, 8.4 Hz, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 158.7, 158.3, 148.0, 142.9, 133.0, 129.8, 129.7, 128.8, 128.7, 128.4, 127.0, 115.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9ClNO2 258.0316; found 258.0314. 7-Trifluoromethyl-2-phenyl-4H-3,1-benzoxazin-4-one (2l) 24 h, 5% EtOAc-hexanes, yield: 57.8 mg (88%, white solid); mp 106–107 °C; IR (neat): νmax 1758, 1611, 1573, 1475, 1233, 1173, 1125, 1017, 927, 899, 779 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.38–8.28 (m, 3H), 7.97 (s, 1H), 7.73 (d, J = 7.9 Hz, 1H), 7.64–7.58 (m, 1H), 7.56–7.49 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 158.4, 158.3, 147.3, 138.0 (q, C–F, 2 J C–F = 33 Hz), 133.2, 129.6, 128.9, 128.5, 124.6 (q, C–F, 3 J C–F = 4 Hz), 124.3 (q, C–F, 3 J C–F = 4 Hz), 123.0 (q, C–F, 1 J C–F = 274 Hz), 119.5; 19F NMR (376 MHz, CDCl3) δ – 66.7 (s); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H9F3NO2 292.0580; found 292.0575. 7-Nitro-2-phenyl-4H-3,1-benzoxazin-4-one (2m) 24 h, 40% CH2Cl2-hexanes, yield: 5.7 mg (9%, yellow solid); mp 175–176 °C; IR (neat): νmax 1756, 1631, 1610, 1530, 1353, 1298, 1077, 1027 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J = 2.0 Hz, 1H), 8.42 (d, J = 8.6 Hz, 1H), 8.37–8.31 (m, 2H), 8.29 (dd, J = 2.0, 8.6 Hz, 1H), 7.67–7.61 (m, 1H), 7.59–7.52 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.0, 157.9, 152.9, 148.1, 133.6, 130.3, 129.3, 129.0, 128.7, 122.5, 122.0, 121.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9N2O4 269.0557; found 269.0557. 6,8-Dimethyl-2-phenyl-4H-3,1-benzoxazin-4-one (2n) 24 h, 5% EtOAc-hexanes, yield: 40.3 mg (72%, pale red solid); mp 144–146 °C; IR (neat): νmax 1748, 1626, 1578, 1495, 1334, 1247, 1055 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.36–8.24 (m, 2H), 7.86 (s, 1H), 7.58–7.44 (m, 4H), 2.61 (s, 3H), 2.42 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 160.3, 155.1, 143.1, 138.6, 137.9, 135.9, 132.2, 130.7, 128.6, 128.1, 125.8, 116.6, 21.2, 16.9; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C16H14NO2 252.1019; found 252.1017. 6,8-Dichloro-2-phenyl-4H-3,1-benzoxazin-4-one (2o) 24 h, 5% EtOAc-hexanes, yield: 57.1 mg (87%, white solid); mp 159–160 °C; IR (neat): νmax 1769, 1608, 1577, 1458, 1319, 1291, 1260, 1061, 877, 788 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.37–8.28 (m, 2H), 8.10 (d, J = 2.3 Hz, 1H), 7.85 (d, J = 2.3 Hz, 1H), 7.64–7.57 (m, 1H), 7.56–7.48 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 157.8, 142.5, 136.7, 133.5, 133.3, 133.1, 129.5, 128.9, 128.7, 126.7, 119.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H8Cl2NO2 291.9927; found 291.9923. 2-(o-Tolyl)-4H-3,1-benzoxazin-4-one (2p) 10 h, 5% EtOAc-hexanes, yield: 25.6 mg (48%, white solid); mp 113–114 °C; IR (neat): νmax 1752, 1606, 1567, 1467, 1287, 1233, 1058, 1030, 1011 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.25 (dd, J = 1.4, 7.9 Hz, 1H), 8.06–8.00 (m, 1H), 7.86–7.79 (m, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.57–7.50 (m, 1H), 7.45–7.40 (m, 1H), 7.36–7.30 (m, 2H), 2.73 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.7, 158.3, 146.8, 139.1, 136.4, 131.9, 131.5, 130.1, 129.8, 128.4, 128.3, 127.2, 126.0, 116.7, 22.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO2 238.0863; found 238.0859. 2-(m-Tolyl)-4H-3,1-benzoxazin-4-one (2q) 24 h, 5% EtOAc-hexanes, yield: 54.6 mg (91%, white solid); mp 119–121 °C; IR (neat): νmax 1758, 1621, 1602, 1472, 1259, 1062, 1009 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.24 (dd, J = 1.6, 7.7 Hz, 1H), 8.16–8.05 (m, 2H), 7.82 (ddd, J = 1.6, 7.7, 8.1 Hz, 1H), 7.69 (dd, J = 1.1, 8.1 Hz, 1H), 7.51 (ddd, J = 1.1, 7.7, 7.7 Hz, 1H), 7.43–7.34 (m, 2H), 2.45 (s, 3H);13C­{1H} NMR (101 MHz, CDCl3) δ 159.6, 157.3, 147.0, 138.6, 136.5, 133.4, 130.1, 128.8, 128.6, 128.5, 128.1, 127.2, 125.5, 117.0, 21.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO2 238.0863; found 238.0859. 2-(p-Tolyl)-4H-3,1-benzoxazin-4-one (2r) 24 h, 5% EtOAc-hexanes, yield: 46.8 mg (88%, white solid); mp 151–153 °C; IR (neat): νmax 1756, 1610, 1571, 1475, 1261, 1062, 1010 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.30–8.09 (m, 3H), 7.80 (ddd, J = 1.3, 7.7, 7.7 Hz, 1H), 7.66 (d, J = 8.2 Hz, 1H), 7.49 (dd, J = 7.7, 7.7 Hz, 1H), 7.30 (d, J = 8.2 Hz, 2H), 2.43 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.6, 157.3, 147.1, 143.4, 136.4, 129.5, 128.5, 128.3, 127.9, 127.4, 127.1, 116.9, 21.6; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO2 238.0863; found 238.0859. 2-(4-Methoxyphenyl)-4H-3,1-benzoxazin-4-one (2s) 24 h, 5% EtOAc-hexanes, yield: 48.6 mg (85%, white solid); mp 147–148 °C; IR (neat): νmax 1754, 1603, 1568, 1511, 1474, 1302, 1255, 1171, 1064, 1011 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.29–8.23 (m, 2H), 8.21 (dd, J = 1.3, 8.0 Hz, 1H), 7.79 (ddd, J = 1.5, 7.7, 7.7 Hz, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.47 (ddd, J = 0.9, 7.7, 7.7 Hz, 1H), 7.03–6.95 (m, 2H), 3.89 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 163.3, 159.8, 157.1, 147.3, 136.5, 130.3, 128.5, 127.7, 126.9, 122.5, 116.7, 114.1, 55.5; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H12NO3 254.0812; found 254.0808. 2-(4-Fluorophenyl)-4H-3,1-benzoxazin-4-one (2t) 24 h, 5% EtOAc-hexanes, yield: 47.3 mg (87%, white solid); mp 173–174 °C; IR (neat): νmax 1760, 1591, 1508, 1473, 1261, 1161, 1107, 1007 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.36–8.29 (m, 2H), 8.23 (dd, J = 1.4, 7.9 Hz, 1H), 7.83 (ddd, J = 1.4, 7.3, 8.1 Hz, 1H), 7.67 (dd, J = 0.6, 8.1 Hz, 1H), 7.52 (ddd, J = 1.4, 7.3, 7.9 Hz, 1H), 7.23–7.15 (m, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 165.6 (d, C–F, 1 J C–F = 253 Hz), 159.3, 156.2, 146.9, 136.6, 130.7 (d, C–F, 3 J C–F = 9 Hz), 128.6, 128.3, 127.1, 126.4 (d, C–F, 4 J C–F = 3 Hz), 116.9, 116.0 (d, C–F, 2 J C–F = 22 Hz); 19F NMR (376 MHz, CDCl3) δ – 109.07 – – 109.15 (m); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9FNO2 242.0612; found 242.0608. 2-(4-(Trifluoromethyl)­phenyl)-4H-3,1-benzoxazin-4-one (2u) 32 h, 5% EtOAc-hexanes, yield: 46.7 mg (72%, white solid); mp 100–101 °C; IR (neat): νmax 1767, 1618, 1474, 1325, 1257, 1170, 1128, 1072 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.49–8.39 (m, 2H), 8.26 (ddd, J = 0.5, 1.1, 8.2 Hz, 1H), 7.86 (ddd, J = 1.5, 7.4, 9.1 Hz, 1H), 7.82–7.75 (m, 2H), 7.72 (ddd, J = 0.5, 1.1, 8.2 Hz, 1H), 7.57 (ddd, J = 1.2, 7.4, 7.8 Hz, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.0, 155.7, 146.5, 136.7, 134.0 (q, C–F, 2 J C–F = 33 Hz), 133.5 (q, C–F, 5 J C–F = 1 Hz), 128.9, 128.7, 128.6, 127.5, 125.7 (q, C–F, 3 J C–F = 4 Hz), 123.6 (q, C–F, 1 J C–F = 274 Hz), 117.1; 19F NMR (376 MHz, CDCl3) δ – 66.22 (s); HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H9F3NO2 292.0580; found 292.0574. 2-(4-Nitrophenyl)-4H-3,1-benzoxazin-4-one (2v) 32 h, 10% EtOAc-hexanes, yield: 7.8 mg (13%, orange solid); mp 198–200 °C; IR (neat): νmax 1768, 1596, 1519, 1476, 1358, 1257, 1066, 1002 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.50 (d, J = 8.7 Hz, 2H), 8.36 (d, J = 8.7 Hz, 2H), 8.28 (d, J = 7.7 Hz, 1H), 7.89 (dd, J = 7.7, 7.7 Hz, 1H), 7.75 (d, J = 7.7 Hz, 1H), 7.60 (dd, J = 7.7, 7.7 Hz, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 158.7, 155.0, 150.2, 146.3, 136.9, 135.9, 129.3, 129.2, 128.8, 127.7, 123.9, 117.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C14H9N2O4 269.0557; found 269.0553. 2-(Naphthalen-2-yl)-4H-3,1-benzoxazin-4-one (2w) 32 h, 5% EtOAc-hexanes, yield: 41.3 mg (36%, orange solid); mp 202–204 °C; IR (neat): νmax 1753, 1603, 1571, 1470, 1318, 1267, 1193, 1058, 1012 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.84 (s, 1H), 8.37 (dd, J = 1.4, 8.7 Hz, 1H), 8.27 (d, J = 7.8 Hz, 1H), 8.00 (d, J = 7.8 Hz, 1H), 7.95 (d, J = 8.7 Hz, 1H), 7.92–7.81 (m, 2H), 7.74 (d, J = 8.0 Hz, 1H), 7.64–7.49 (m, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.7, 157.2, 147.1, 136.6, 135.3, 132.8, 129.5, 129.4, 128.6, 128.5, 128.3, 128.2, 127.8, 127.4, 127.3, 126.9, 124.1, 117.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C18H12NO2 274.0863; found 274.0856. 2-(Pyridin-2-yl)-4H-3,1-benzoxazin-4-one (2x) 32 h, 20% EtOAc-hexanes, yield: 7.4 mg (15%, yellow solid); mp 151–153 °C; IR (neat): νmax 1760, 1602, 1474, 1324, 1245, 1079, 1036 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.89 (ddd, J = 1.0, 1.6, 4.8 Hz, 1H), 8.37 (ddd, J = 1.0, 1.0, 8.0 Hz, 1H), 8.28 (ddd, J = 1.0, 1.0, 8.0 Hz, 1H), 7.98–7.82 (m, 3H), 7.61 (ddd, J = 2.7, 5.7, 10.1 Hz, 1H), 7.50 (ddd, J = 1.0, 4.8, 7.6 Hz, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.0, 155.5, 150.6, 148.0, 146.5, 137.2, 136.7, 129.1, 128.7, 128.0, 126.4, 124.1, 117.4; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C13H9N2O2 225.0659; found 225.0654. 2-(Thiophen-2-yl)-4H-3,1-benzoxazin-4-one (2y) 32 h, 5% EtOAc-hexanes, yield: 38.1 mg (74%, pale red solid); mp 134–135 °C; IR (neat): νmax 1761, 1597, 1472, 1423, 1268, 1222, 1061, 1025 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.22 (ddd, J = 0.5, 1.6, 8.1 Hz, 1H), 7.97 (dd, J = 1.2, 3.9 Hz, 1H), 7.81 (ddd, J = 2.0, 6.8, 8.1 Hz, 1H), 7.69–7.59 (m, 2H), 7.49 (ddd, J = 1.2, 7.2, 7.9 Hz, 1H), 7.18 (dd, J = 3.9, 5.0 Hz, 1H); 13C­{1H} NMR (101 MHz, CDCl3) δ 159.0, 153.7, 147.1, 136.6, 134.2, 132.3, 131.7, 128.7, 128.3, 127.9, 126.8, 116.7; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C12H8NO2S 230.0270; found 230.0267. 2-Methyl-4H-3,1-benzoxazin-4-one (2z) 24 h, 5% EtOAc-hexanes, yield: 5.3 mg (15%, white solid); mp 114–116 °C; IR (neat): νmax 1784, 1701, 1613, 1463, 1376, 1329, 1242 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.10 (dd, J = 0.8, 8.4 Hz, 1H), 7.90 (dd, J = 0.8, 7.8 Hz, 1H), 7.79 (ddd, J = 1.2, 7.8, 7.8 Hz, 1H), 7.40 (ddd, J = 0.8, 7.8, 7.8 Hz, 1H), 2.51 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 165.6, 163.4, 144.7, 136.7, 125.7, 125.6, 114.7, 111.6, 22.1; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C9H8NO2 162.0550; found 162.0548. 2-Ethyl-4H-3,1-benzoxazin-4-one (2aa) 10 h, 60% CH2Cl2-hexanes, yield: 5.7 mg (14%, pink solid); mp 86–88 °C; IR (neat): νmax 1793, 1706, 1608, 1476, 1464, 1375, 1333, 1224, 1012 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J = 8.4 Hz, 1H), 7.89 (dd, J = 0.8, 7.8 Hz, 1H), 7.78 (ddd, J = 1.2, 7.8, 7.8 Hz, 1H), 7.38 (ddd, J = 0.8, 7.8, 7.8 Hz, 1H), 2.84 (q, J = 7.4 Hz, 2H), 1.29 (t, J = 7.4 Hz, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 169.4, 163.5, 144.9, 136.6, 125.6, 114.7, 111.5, 27.8, 7.8; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C10H10NO2 176.0706; found 176.0707. 2-Cyclopropyl-4H-3,1-benzoxazin-4-one (2bb) 10 h, 20% EtOAc-hexanes, yield: 23.5 mg (56%, white solid); mp 107–108 °C; IR (neat): νmax 1748, 1636, 1472, 1291, 1263, 1039 cm–1; 1H NMR (600 MHz, CDCl3) δ 8.13 (d, J = 7.6 Hz, 1H), 7.75 (dd, J = 8.0, 8.0 Hz, 1H), 7.48 (d, J = 8.0 Hz, 1H), 7.42 (dd, J = 7.6, 7.6 Hz, 1H), 1.99–1.90 (m, 1H), 1.31–1.25 (m, 2H), 1.13–1.05 (m, 2H); 13C­{1H} NMR (151 MHz, CDCl3) δ 164.2, 159.6, 146.9, 136.5, 128.4, 127.4, 126.0, 116.6, 14.3, 9.3; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C11H10NO2 188.0706; found 188.0705. 6-Nitro-2-(m-tolyl)-4H-3,1-benzoxazin-4-one (2cc) 24 h, 40% CH2Cl2-hexanes, yield: 5.3 mg (8%, yellow solid); mp 187–189 °C; IR (neat): νmax 1778, 1609, 1576, 1536, 1473, 1339, 1261, 1084 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.09 (d, J = 2.6 Hz, 1H), 8.62 (dd, J = 2.6, 8.8 Hz, 1H), 8.21–8.11 (m, 2H), 7.34 (d, J = 8.8 Hz, 1H), 7.49–7.41 (m, 2H), 2.48 (s, 3H); 13C­{1H} NMR (101 MHz, CDCl3) δ 160.2, 157.8, 151.5, 146.4, 139.0, 134.8, 130.7, 129.4, 129.1, 128.9, 128.6, 126.2, 124.8, 117.3, 21.4; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C15H11N2O4 283.0713; found 283.0714. 2-Benzyl-1-(benzyloxy)-6-nitro-2-phenylindolin-3-one (3m) 40% CH2Cl2-hexanes, yield: 15.8 mg (16%, orange solid); mp 139–141 °C; IR (neat): νmax 1720, 1618, 1531, 1443, 1535, 1261, 1033 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.53–7.36 (m, 11H), 7.33–7.27 (m, 2H), 7.20–7.11 (m, 2H), 7.06–6.89 (m, 3H), 4.83 (ABq, J = 11.1 Hz, 2H), 3.88 (ABq, J = 13.3 Hz, 2H); 13C­{1H} NMR (101 MHz, CDCl3) δ 198.1, 161.4, 153.2, 138.3, 135.5, 134.2, 130.8, 129.3, 129.0, 128.9, 128.8, 128.7, 127.9, 127.4, 126.9, 124.4, 124.2, 115.8, 106.8, 81.8, 78.8, 38.8; HRMS (ESI-Orbitrap) m/z (M + H)+ calcd for C28H23N2O4 451.1652; found 451.1647 (CCDC 2528871). Synthesis of Compound 4 (a Key Synthon for (±)-Yaequinolone A2) To a −78 °C solution of benzoxazinone 2a (500.0 mg, 2.24 mmol, 1.0 equiv) in dry THF (22 mL, 0.1 M) was added dropwise via a cannula with p-anisylmagnesium bromide, prepared from 4-anisyl bromide (1.27 g, 0.86 mL, 6.8 mmol, 3.0 equiv) and magnesium turnings (182.0 mg, 7.5 mmol, 3.1 equiv) in THF (7 mL). The reaction mixture was allowed to stir at −78 °C while warming to room temperature over 16 h before it was quenched with saturated aqueous NH4Cl. The mixture was extracted with EtOAc (3 × 20 mL). The combined organic phases were washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (20% EtOAc-hexanes) to afford N-(2-(4-methoxybenzoyl)­phenyl)­benzamide (386.2 mg, 52% yield). This intermediate (373.0 mg, 1.13 mmol, 1.0 equiv) was taken up in MeOH (5 mL, 0.2 M) and was added with 10 M aqueous NaOH (3 mL). After heating at reflux for 4 h, the mixture was cooled to rt and extracted with EtOAc (3 × 20 mL). The combined organic phases were washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, filtered, and concentrated to crude material. The crude product was purified by column chromatography on silica gel (60% CH2Cl2-hexanes) to afford 2- aminophenone 4 (185.1 mg, 83% yield). (2-Aminophenyl)­(4-methoxyphenyl)­methanone (4) 60% CH2Cl2-hexanes, yield: 185.1 mg (43% over two steps, yellow solid); 1H NMR (300 MHz, CDCl3) δ 7.73–7.63 (m, 2H), 7.46 (dd, J = 1.5, 8.0 Hz, 1H), 7.28 (ddd, J = 1.5, 7.1, 8.3 Hz, 1H), 7.00–6.91 (m, 2H), 6.73 (dd, J = 0.9, 8.3 Hz, 1H), 6.62 (ddd, J = 0.9, 7.1, 8.0 Hz, 1H), 5.85 (s, 2H), 2.88 (s, 3H). Characterization data are in agreement with the literature. Radical Inhibition Experiments Two control experiments were conducted under otherwise identical conditions. A sealed tube equipped with a magnetic bar was charged with 1a (50.3 mg, 0.224 mmol, 1.0 equiv), 2-picolinic acid (1.4 mg, 0.0112 mmol, 5 mol %), either TEMPO (38.5 mg, 0.246 mmol, 1.1 equiv) or BHT (54.3 mg, 0.246 mmol, 1.1 equiv), and toluene (2.2 mL, 0.1 M). The reaction mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) for 10 h at rt, with the light source positioned 2 cm from the sealed tube. After completion, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with saturated aqueous NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. Purification of the residue by column chromatography on silica gel (5% EtOAc-hexanes) afforded 2a as a white solid in 92% yield (46.4 mg) in the presence of TEMPO and 88% yield (44.3 mg) in the presence of BHT. Atmosphere Control Experiments Two experiments were conducted under identical conditions, differing only in the atmosphere. A sealed tube equipped with a magnetic bar was charged with 1a (50.1–50.3 mg, 0.224 mmol, 1.0 equiv), 2-picolinic acid (1.4 mg, 0.0112 mmol, 5 mol %), and toluene (2.2 mL, 0.1 M). The reaction mixture was either degassed with argon or purged with O2 for 15 min, then sealed tightly. The mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) for 10 h at rt, with the light source positioned 2 cm from the sealed tube. After completion, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with saturated aqueous NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. Purification of the residue by column chromatography on silica gel (5% EtOAc-hexanes) afforded 2a as a white solid in 93% yield (46.5 mg) under argon and 81% yield (40.7 mg) under O2. Triplet Energy Quenching Experiment A sealed tube equipped with a magnetic bar was charged with 1a (50.1 mg, 0.224 mmol, 1.0 equiv), 2-picolinic acid (1.4 mg, 0.0112 mmol, 5 mol %), 2,5-dimethyl-2,4-hexadiene (64 μL, 49.4 mg, 0.448 mmol, 2.0 equiv), and toluene (2.2 mL, 0.1 M). The reaction mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) for 10 h at rt, with the light source positioned 2 cm from the sealed tube. After completion, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with saturated aqueous NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. Purification of the crude material by column chromatography on silica gel (5% EtOAc-hexanes) afforded 2a (20.8 mg, 42% yield) as a white solid. Ketene–Imine Trapping Experiment A sealed tube equipped with a magnetic bar was charged with 1a (50.2 mg, 0.224 mmol, 1.0 equiv), 2-picolinic acid (1.4 mg, 0.0112 mmol, 5 mol %), and EtOH (2.2 mL, 0.1 M). The reaction mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) for 12 h at rt, with the light source positioned 2 cm from the sealed tube. After completion, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with saturated aqueous NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. Purification of the crude material by column chromatography on silica gel (5% EtOAc-hexanes) afforded 2a (39.5 mg, 79% yield) as a white solid, along with a trace amount of compound 5, detected by HRMS and confirmed by 1H NMR spectroscopy. The NMR data are consistent with those reported in the literature. Radical-Trapping Experiment of Compound 1m A sealed tube equipped with a magnetic bar was charged with compound 1m (56.3 mg, 0.210 mmol, 1.0 equiv), 2-picolinic acid (1.3 mg, 0.0105 mmol, 5 mol %), TEMPO (36.1 mg, 0.231 mmol, 1.1 equiv), and toluene (2.1 mL, 0.1 M). The reaction mixture was stirred under LED irradiation (Kessil PR160L-Gen 2, 370 nm, 40 W, 100% intensity) for 24 h at rt, with the light source positioned 2 cm from the sealed tube. After completion, the mixture was quenched with saturated aqueous NaHCO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with saturated aqueous NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. Purification of the crude material by column chromatography on silica gel (5% EtOAc-hexanes) afforded compound 3m (15.3 mg, 15% yield) as an orange solid, along with a trace amount of radical adduct 6 (detected by HRMS). Supplementary Material